Core Scientific (CORZW) Gains from Investment Securities (2022 - 2026)

Core Scientific has reported Gains from Investment Securities for 4 years, with the latest figure at $1.0 billion in Q2 2026.

• Quarterly Gains from Investment Securities rose 13.3% year-over-year to $1.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $822.9 million (up 30.91% YoY) and the FY2025 annual result came in at $34.0 million, down 97.66% from the prior year.
• Gains from Investment Securities grew to $1.0 billion in Q2 2026 per CORZW's latest filing, from $31.8 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $1.0 billion in Q2 2026 and troughed at -$634.3 million in Q1 2025.
• A 4-year average of $158.8 million and a median of $15.7 million in 2022 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities plunged 3349.16% in 2025, then soared 105.02% in 2026.
• Over 4 years, Gains from Investment Securities stood at -$5.0 million in 2022, then surged by 4692.79% to $227.4 million in 2024, then plunged by 245.55% to -$331.0 million in 2025, then surged by 416.14% to $1.0 billion in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.0 billion, $31.8 million, and -$331.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.